Skip to content
Monday 14 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,650.44
+0.39%
DAX
25,568.56
+0.82%
CAC 40
8,179.77
0.00%
STOXX 50
6,325.13
+0.90%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 25 May 2021 5:31 pm

English mass event trials only led to 15 Covid cases out of 58,000 people

By: Stefan Boscia

Add as a preferred source on Google
POUND-STERLING-GAINS-21-JUNE-REOPENING
Financially struggling students cause UK nightclub operator to pivot towards bars.

England’s collection of mass event trials have been deemed a “real success”, with only 15 positive Covid cases out of 58,000 people.

Culture secretary Oliver Dowden said the results showed “we’re making good progress along the line to bring the West End back to life again”.

The government put on a series of indoor events in England last month, including a club night in Liverpool without social distancing or masks, as a trial run before Covid restrictions are set to be removed next month.

Other events included the Brit Awards, the FA Cup final and the snooker championships.

Dowden told the Evening Standard that there were just four Covid cases across 17 days of the snooker championships, zero cases from the Brits and nine cases at the club night in Liverpool.

“I hope by June 21 we will be lighting up the West End again, having full stadiums and bringing light and Technicolor back into our national life again,” he said.

The government is increasingly confident it will be able to go ahead with its plan to shed most, if not all, Covid restrictions by next month.

This could include scrapping the one-metre plus rule and face mask requirements, however exact measures will not be announced before a social distancing review led by Michael Gove is published.

When asked if theatres will be able to operate without social distancing from next month, Dowden said he was “very hopeful”.

He said: “There’s two questions. Can we go ahead with stage four on June 21? I hope we can.  We’re definitely not ruling it out.

“Then the second question is the ‘how’ and this is about the sort of mitigations that you might have to have in place.”

Read more

Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Politics
  • Retail

Trending Articles

  • Wetherspoon boss: ‘Not up to Burnham’ to choose who is on the high street 

  • Badger Beer maker Hall & Woodhouse doubles profit ahead of tie-up with James May

  • Four interest rate hikes loom despite surprise economic growth

  • Primark sales slip as owner dresses up retailer for demerger

  • Lotus, Porsche and Corvette: the best sports cars to buy in 2026

More from Morning Wire

  • Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

    Business Wire
  • Surge in third-party funding sparks wave in FTSE shareholder lawsuits

    Lawsuit
    UK retail investors are eyeing emerging markets for potential higher returns amid tariff turmoil
  • Silence Therapeutics to Participate in Three September Investor Conferences

    Business Wire
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
  • SCP Standard Capital Partners AG: VANEA Defence Unveils ATOMZA®, the First Production-Ready Drone Defence System for Civilian Operators

    Business Wire
  • Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results

    Business Wire
  • Transition Bio Partners with the Little Warrior Foundation

    Business Wire
  • U.S. FDA approves ViiV Healthcare’s Tivicay PD, helping close a critical HIV treatment gap for young children

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook